Impact of KRAS G12C mutation in patients with advanced non-squamous
non-small cell lung cancer treated with first-line
pembrolizumab monotherapy

Lien : https://doi.org/10.1016/j.lungcan.2022.10.005

Télécharger : KRAS G12C

Grégoire Justeau, Eric Huchot, Yannick Simonneau, Magali Roa, Jacques Le Treut, Gwenaelle Le Garff, Olivier Bylicki, Roland Schott, Anne-Sophie Bravard, Marie Tiercin, Régine Lamy, Gonzague De Chabot, Adina Marty, Diane Moreau, Chrystèle Locher, Cyril Bernier, Christos Chouaid, Renaud Descourt

 

Brief Report: First-line Pembrolizumab in Metastatic Non-Small Cell Lung Cancer Habouring MET Exon 14 Skipping Mutation and PD-L1 ≥50% (GFPC 01-20 Study)

Lien : https://doi.org/10.1016/j.cllc.2022.09.002

Télécharger : MET

Florian Guisier, Renaud Descourt, Hélène Babey, Eric Huchot, Lionel Falchero, Rémi Veillon, Alexis B. Cortot, Claire Tissot, Christos Chouaid, Chantal Decroisette

 

Paclitaxel–bevacizumab combination in advanced non-squamous non-small-cell lung cancer (NSCLC): AVATAX, a retrospective multicentric study

Lien: https://doi.org/10.1177/17588359221099399

Télécharger : Atavax

Geoffroy Bilger , Anne-Claire Toffart, Marie Darrason, Michaël Duruisseaux, Lucie Ulmer, Pascal Wang, Etienne Giroux Leprieur, Nicolas Girard, Marie Ange Massiani, Paul Bore, Renaud Descourt, Julian Pinsolle, Solene Valery, Isabelle Monnet, Aurélie Swalduz, Claire Tissot, Pierre Fournel, Anne Baranzelli, Alexis B. Cortot and Chantal Decroisette

 

 

First‑line single‑agent pembrolizumab for PD‑L1‑positive (tumor proportion score ≥ 50%) advanced non‑small cell lung cancer in the real world: impact in brain metastasis: a national French multicentric cohort (ESCKEYP GFPC study)

 Lien: https://doi.org/10.1007/s00262-022-03232-2

Télécharger : Esceyp

Renaud Descourt, Laurent Greillier, Maurice Perol, Charles Ricordel, Jean‑Bernard Auliac, Lionel Falchero, Radj Gervais, Rémi Veillon, Sabine Vieillot, Florian Guisier, Marie Marcq, Grégoire Justeau, Laurence Bigay‑Game, Marie Bernardi, Pierre Fournel, Hélène Doubre, Julian Pinsolle, Karim Amrane, Christos Chouaïd, Chantal Decroisette

 

 

ROS-1 Fusions in Non-Small-Cell Lung Cancer: Evidence to Date

Télécharger : ROS1

 

First‑Line Treatment of Advanced Non‑Small‑Cell Lung Cancer with Immune‑Checkpoint Inhibitors: New Combinations and Long‑Term Data

Lien: https://doi.org/10.1007/s00262-021-03089-x

Télécharger : Article

A definitive prognostication system for patients with thoracic malignancies diagnosed
with COVID-19: an update from the TERAVOLT registry.

Lien: https://doi.org/10.1016/j.jtho.2021.12.015

Télécharger :Teravolt

Jennifer G. Whisenant, Javier Baena, Alessio Cortellini, Li-Ching Huang, Giuseppe Lo Russo, Luca Porcu, Selina K. Wong, Christine M. Bestvina, Matthew D. Hellmann, Elisa Roca, Hira Rizvi, Isabelle Monnet, Amel Boudjemaa, Jacobo Rogado, Giulia Pasello, Natasha B. Leighl, Oscar Arrieta, Avinash Aujayeb, Ullas Batra, Ahmed Y. Azzam, Mojca Unk, Mohammed A. Azab, Ardak N. Zhumagaliyeva, Carlos GomezMartin, Juan B. Blaquier, Erica Geraedts, Giannis Mountzios, Gloria Serrano-Montero, Niels Reinmuth, Linda Coate, Melina Marmarelis, Carolyn J. Presley, Fred R. Hirsch, Pilar Garrido, Hina Khan, Alice Baggi, Celine Mascaux, Balazs Halmos, Giovanni L. Ceresoli, Mary J. Fidler, Vieri Scotti, Anne-Cécile Métivier, Lionel Falchero, Enriqueta Felip, Carlo Genova, Julien Mazieres, Umit Tapan, Julie Brahmer, Emilio Bria, Sonam Puri, Sanjay Popat, Karen L. Reckamp, Floriana Morgillo, Ernest Nadal, Francesca Mazzoni, Francesco Agustoni, Jair Bar, Federica Grosso, Virginie Avrillon, Jyoti D. Patel, Fabio Gomes, Ehab Ibrahim, Annalisa Trama, Anna C. Bettini, Fabrice Barlesi, Anne-Marie Dingemans, Heather Wakelee, Solange Peters, Leora Horn, Marina Chiara Garassino, Valter Torri, On behalf of the TERAVOLT study group

 

 

Immune-Checkpoint Inhibitors for Malignant Pleural Mesothelioma: A French, Multicenter, Retrospective Real-World Study

Lien: https://doi.org/10.3390/cancers14061498

Télécharger MesoImmun

Jean-Baptiste Assié , Florian Crépin, Emmanuel Grolleau, Anthony Canellas, Margaux Geier, Aude Grébert-Manuardi, Nabila Akkache, Aldo Renault, Pierre-Alexandre Hauss, Marielle Sabatini, Valentine Bonnefoy, Alexis Cortot, MarieWislez, Clément Gauvain, Christos Chouaïd, Arnaud Scherpereel and Isabelle Monnet

 

Tailoring maintenance chemotherapy upon response to induction chemotherapy as compared with pemetrexed continuation maintenance in advanced non-squamous NSCLC patients: Results of the IFCT-GFPC-1101 multicenter randomized phase III trial

Lien : https://doi.org/10.1016/j.lungcan.2021.11.014

Télécharger IFCT-GFPC1101

Pierre-Jean Souquet, Clarisse Audigier-Valette, Olivier Molinier, Alexis Cortot, Jacques Margery, Lionel Moreau, Radj Gervais, Fabrice Barlesi, Eric Pichon, Gerard Zalcman, Patrick Dumont, Nicolas Girard, Michel Poudenx, Julien Mazieres, Jacques Cadranel, Didier Debieuvre, Jérôme Dauba, Alexandra Langlais, Franck Morin, Denis Moro-Sibilot, Virginie Westeel, Maurice Pérol

 

Brigatinib for Pretreated, ALK-Positive, Advanced Non-Small-Cell Lung Cancers: Long-Term Follow-Up and Focus on Post-Brigatinib Lorlatinib Efficacy in the Multicenter, Real-World BrigALK2 Study

Lien : https://doi.org/10.3390/cancers14071751

Télécharger BrigalK2